FI955103A0 - Endoteliinireseptorin antagonisteja - Google Patents

Endoteliinireseptorin antagonisteja

Info

Publication number
FI955103A0
FI955103A0 FI955103A FI955103A FI955103A0 FI 955103 A0 FI955103 A0 FI 955103A0 FI 955103 A FI955103 A FI 955103A FI 955103 A FI955103 A FI 955103A FI 955103 A0 FI955103 A0 FI 955103A0
Authority
FI
Finland
Prior art keywords
endotelinreseptorantagonister
Prior art date
Application number
FI955103A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955103A (fi
Inventor
Russell Donovan Cousins
John Duncan Elliott
Maria Amparo Lago
Jack Dale Leber
Catherine Elizabeth Peishoff
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of FI955103A0 publication Critical patent/FI955103A0/fi
Publication of FI955103A publication Critical patent/FI955103A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/34Unsaturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI955103A 1993-04-27 1995-10-26 Endoteliinireseptorin antagonisteja FI955103A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6681893A 1993-04-27 1993-04-27
PCT/US1994/004603 WO1994025013A1 (fr) 1993-04-27 1994-04-26 Antagonistes des recepteurs de l'endotheline

Publications (2)

Publication Number Publication Date
FI955103A0 true FI955103A0 (fi) 1995-10-26
FI955103A FI955103A (fi) 1995-10-26

Family

ID=22071916

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955103A FI955103A (fi) 1993-04-27 1995-10-26 Endoteliinireseptorin antagonisteja

Country Status (29)

Country Link
EP (1) EP0699069B9 (fr)
JP (1) JP3346571B2 (fr)
KR (1) KR100331667B1 (fr)
CN (1) CN1129428C (fr)
AP (1) AP573A (fr)
AT (1) ATE213156T1 (fr)
AU (1) AU682038B2 (fr)
BR (1) BR9406572A (fr)
CA (1) CA2160914A1 (fr)
CZ (1) CZ291189B6 (fr)
DE (1) DE69429861T2 (fr)
DK (1) DK0699069T3 (fr)
DZ (1) DZ1773A1 (fr)
ES (1) ES2172535T3 (fr)
FI (1) FI955103A (fr)
HK (1) HK1012252A1 (fr)
HU (2) HUT73763A (fr)
IL (1) IL109443A0 (fr)
MA (1) MA23172A1 (fr)
NO (1) NO313754B1 (fr)
NZ (1) NZ266314A (fr)
PL (1) PL175392B1 (fr)
PT (1) PT699069E (fr)
RU (1) RU2130920C1 (fr)
SG (1) SG49667A1 (fr)
SI (1) SI9400195B (fr)
SK (1) SK130595A3 (fr)
TW (1) TW330204B (fr)
WO (1) WO1994025013A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0763035A4 (fr) * 1994-06-09 1997-10-01 Smithkline Beecham Corp Antagonistes du recepteur de l'endotheline
JPH10501812A (ja) * 1994-06-20 1998-02-17 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗薬
EP0799225A4 (fr) * 1994-12-23 1998-03-25 Smithkline Beecham Corp Composes et procedes associes
ZA969363B (en) * 1995-11-08 1997-11-18 Smithkline Beecham Corp An improved process for preparing aromatic ring-fused cyclopentane derivatives.
US6162932A (en) * 1995-11-08 2000-12-19 Smithkline Beecham Corporation Stereoselective synthesis of endothelin receptor antagonists
CA2236924A1 (fr) * 1995-11-08 1997-05-15 Smithkline Beecham Corporation Synthese stereoselective d'antagonistes de recepteurs d'endothelines
US6080862A (en) * 1995-11-08 2000-06-27 Smithkline Beecham Corporation Stereoselective synthesis of endothelin receptor antagonists
US5977117A (en) * 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5932553A (en) 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
CN1234029A (zh) 1996-08-27 1999-11-03 盐野义制药株式会社 色烯-3-羚酸衍生物
US5929106A (en) * 1997-10-27 1999-07-27 Smithkline Beecham Corporation Endothelin receptor antagonists
US6025328A (en) 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents
US7141603B2 (en) 1999-02-19 2006-11-28 The Regents Of The University California Antitumor agents
US6410554B1 (en) 1998-03-23 2002-06-25 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
DE69909273T2 (de) * 1998-04-09 2004-04-22 Merck & Co., Inc. (A New Jersey Corp.) Phosphat-vermittelte cyclisierung
AR022229A1 (es) 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
KR20070006774A (ko) 2004-03-17 2007-01-11 노파르티스 아게 치료에서 레닌 억제제의 용도
US7423176B2 (en) 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
JP2008524277A (ja) 2004-12-21 2008-07-10 エフ.ホフマン−ラ ロシュ アーゲー テトラリン及びインダン誘導体、並びにそれらの5−ht拮抗薬としての使用
US20100040666A1 (en) * 2005-06-24 2010-02-18 Hiroshi Azuma Method for Control of Drug Elution Rate and Composition for Coating of Drug-Eluting Stent
ATE527998T1 (de) 2005-08-03 2011-10-15 Univ California Illudin-analoga als krebsmittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67665A (en) * 1991-11-05 1995-04-28 Smithkline Beckman Corp Indane and indene deriv.s as endothelin receptor antagonists, pharmaceutical compn.s contg. them and process for prepg. them

Also Published As

Publication number Publication date
EP0699069A4 (fr) 1996-04-03
DZ1773A1 (fr) 2002-02-17
ATE213156T1 (de) 2002-02-15
NZ266314A (en) 1998-10-28
DE69429861D1 (de) 2002-03-21
PT699069E (pt) 2002-07-31
CN1129428C (zh) 2003-12-03
SK130595A3 (en) 1996-06-05
SG49667A1 (en) 1998-06-15
MA23172A1 (fr) 1994-12-31
NO313754B1 (no) 2002-11-25
SI9400195A (en) 1994-12-31
AP9400636A0 (en) 1994-04-30
EP0699069A1 (fr) 1996-03-06
WO1994025013A1 (fr) 1994-11-10
NO954291D0 (no) 1995-10-26
CZ291189B6 (cs) 2003-01-15
DK0699069T3 (da) 2002-05-27
ES2172535T3 (es) 2002-10-01
HU9503067D0 (en) 1995-12-28
KR100331667B1 (ko) 2002-11-08
TW330204B (en) 1998-04-21
EP0699069B9 (fr) 2003-10-22
IL109443A0 (en) 1994-07-31
PL175392B1 (pl) 1998-12-31
AU6775094A (en) 1994-11-21
AU682038B2 (en) 1997-09-18
CZ283595A3 (en) 1996-03-13
JP3346571B2 (ja) 2002-11-18
SI9400195B (sl) 2003-10-31
AP573A (en) 1997-01-30
CA2160914A1 (fr) 1994-11-10
EP0699069B1 (fr) 2002-02-13
JPH08510211A (ja) 1996-10-29
HUT73763A (en) 1996-09-30
DE69429861T2 (de) 2002-09-19
RU2130920C1 (ru) 1999-05-27
CN1124923A (zh) 1996-06-19
HK1012252A1 (en) 1999-07-30
PL311272A1 (en) 1996-02-05
FI955103A (fi) 1995-10-26
BR9406572A (pt) 1996-01-30
NO954291L (no) 1995-12-21
HU9501931D0 (en) 1995-09-28

Similar Documents

Publication Publication Date Title
DE69407573D1 (de) Fluorsiloxanhydrogele
DE69430498D1 (de) Personenrufübertragungssystem
DE69411848D1 (de) Furanylinsektizide
DE69421035D1 (de) Ringoszillator
DE69431641D1 (de) Hörkapselnanordnung
DE69430989D1 (de) Stromleitungskommunikationsanalysator
DE69432420D1 (de) Bohrgestängeanordnung
DE69429469D1 (de) Halbleiterbildaufnehmer
BR9405832A (pt) Imidazoazinas
DE69429756D1 (de) Difibrillationsgerät
DE69431862D1 (de) Radbremsdrucksteuergerät
DE69413933D1 (de) Antitussiva
DE69331809D1 (de) Viskosimeter
ATA146094A (de) Windsichter
DE59407673D1 (de) 2-Oximino-2-phenyl-acetamide
DE69410500D1 (de) Mehrplattenspieler
DE69432138D1 (de) Spreizspektrumsignalempfänger
DE59410180D1 (de) 4-Cyanophenyliminoheterocyclen
DE59309062D1 (de) Mischer-Trockner
ATA179094A (de) Kettenschloss
ATA194593A (de) Sportschuh
ATA212793A (de) Sportschuh
DE59410298D1 (de) Hefeerntetank
ATE144907T1 (de) Rollbrett
DE69420364D1 (de) Liponucleotide

Legal Events

Date Code Title Description
FD Application lapsed